These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2186764)

  • 1. [Ca antagonists in neurosurgical practice].
    Handa J; Shiino A; Kidooka M
    No To Shinkei; 1990 Jan; 42(1):43-52. PubMed ID: 2186764
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcium antagonists in the management of patients with aneurysmal subarachnoid hemorrhage: a review.
    Adams HP
    Angiology; 1990 Nov; 41(11 Pt 2):1010-6. PubMed ID: 2248423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nervous disease & Ca antagonist].
    Otomo E
    No To Shinkei; 1990 Jan; 42(1):33-41. PubMed ID: 2337488
    [No Abstract]   [Full Text] [Related]  

  • 4. Protective action of calcium channel blockers on Na+,K+-ATPase in gerbil cerebral cortex following ischemia.
    Palmer GC; Palmer SJ; Christie-Pope BC
    J Neurosci Res; 1988 Feb; 19(2):252-7. PubMed ID: 2835493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Calcium channel blockers in therapy of neurologic diseases].
    Wessely P; Wöber-Bingöl C
    Wien Med Wochenschr; 1993; 143(19-20):514-8. PubMed ID: 8135034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of dilceren (nimodipine) on the cerebral circulation in the intact animals and animals subjected to ischemic brain damage].
    Aleksandrin VV; Khaĭlov NA; Mirzoian GR; Gan'shina TS
    Eksp Klin Farmakol; 2002; 65(2):17-9. PubMed ID: 12109284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relevance of the calcium channel blocker nimodipine in the therapy of cerebral aneurysms.
    Maier-Hauff K; Stahl P
    Acta Physiol Hung; 1990; 75 Suppl():197-8. PubMed ID: 2371862
    [No Abstract]   [Full Text] [Related]  

  • 8. [Vascular and neuronal mechanisms of calcium antagonists. Significance in neurological therapy].
    Govoni S; Trabucchi M; Battaini F; Magnoni MS; Paoletti R
    Minerva Med; 1986 Jun; 77(24):1053-8. PubMed ID: 3725133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The usage of calcium channel blockers in acute cerebral ischemia].
    Ara JR; Errea JM; Calderón C; Marzo ME; Serrano C; Hermida I
    Rev Neurol; 1995; 23(120):450. PubMed ID: 7497207
    [No Abstract]   [Full Text] [Related]  

  • 10. Post-treatment of transient focal cerebral ischemia in rats with the novel cerebrovascular-selective Ca2+ channel antagonist (+/-)-(E)-1-(3-fluoro-6,11-dihydrodibenz[b,e]-oxepine-11-yl)-4-(3-pheny l-2-propenyl)-piperazine dimaleate.
    Minato H; Kikuta C; Masuda Y; Fujitani B; Hosoki K
    Arzneimittelforschung; 1997 Jul; 47(7):799-802. PubMed ID: 9272234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of ischemic-induced damage to cerebral adenylate cyclase in gerbils by calcium channel blockers.
    Christie-Pope BC; Palmer GC
    Metab Brain Dis; 1986 Dec; 1(4):249-61. PubMed ID: 3508245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 1-[bis(4-fluorophenyl)methyl]-4-(2,3,4-trimethoxybenzyl) piperazine dihydrochloride, a new synthesized Ca2+ blocker KB-2796, on free fatty acid liberation in ischemic brain in rats.
    Kanazawa T; Kidooka M; Matsuda M; Handa J
    Nihon Geka Hokan; 1986 Nov; 55(6):755-61. PubMed ID: 3606299
    [No Abstract]   [Full Text] [Related]  

  • 13. [Nimodipine and experimental combined disorders of cerebral and coronary circulation].
    Mirzoian RS; Khaĭlov NA; Tsorin IB; Gan'shina TS
    Eksp Klin Farmakol; 2009; 72(2):24-8. PubMed ID: 19441723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical application of Ca2(+)-antagonist for prevention and treatment of cerebral vasospasm].
    Kyoi K; Utsumi S
    Nihon Rinsho; 1989 Aug; 47(8):1831-6. PubMed ID: 2685399
    [No Abstract]   [Full Text] [Related]  

  • 15. Low molecular weight heparin and the treatment of ischemic stroke. Animal results, the reasons for failure in human stroke trials, mechanisms of action, and the possibilities for future use in stroke.
    Jonas S; Quartermain D
    Ann N Y Acad Sci; 2001 Jun; 939():268-70. PubMed ID: 11462779
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of subarachnoid hemorrhage].
    Ohman J
    Duodecim; 1994; 110(5):511-5. PubMed ID: 7555846
    [No Abstract]   [Full Text] [Related]  

  • 17. [Calcium blockers in the therapy of vertebrobasilar insufficiency. Results of animal experiments and clinical studies].
    Hofferberth B
    Fortschr Med; 1984 Jul; 102(27-28):725-8. PubMed ID: 6383990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of calcium channel blockers in the management of cerebral ischemia.
    Schaefer MK; Schaefer RF
    Hawaii Med J; 1987 Dec; 46(12):473, 476, 478-9. PubMed ID: 3127355
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanism of calcium channel inhibition by phenytoin: comparison with classical calcium channel antagonists.
    Messing RO; Carpenter CL; Greenberg DA
    J Pharmacol Exp Ther; 1985 Nov; 235(2):407-11. PubMed ID: 2414431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comprehensive treatment of intracranial aneurysm complicated by postoperative vasospasm].
    Duan A; Ding Y; Hua Y
    Zhonghua Wai Ke Za Zhi; 1996 Jun; 34(6):361-3. PubMed ID: 9594179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.